Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XILLIX FDA APPROVED -- Ignore unavailable to you. Want to Upgrade?

To: Garry K. who wrote (326)	11/9/1998 4:08:00 PM
From: burner	Respond to of 572

Garry, I am pretty frustrated with Xillix right now. For a company with an apparently exciting product there seems to be no market interest. This stock has historically traded at significantly higher levels and you would think there would be interest in it from other larger medical companies at these valuations. The company seems perfectly willing to sit back and take a "poor me--the market undervalues us" approach to handling the present situation. I still follow NVO and wish I would have bought it at 31 cents rather than this one at a buck. Regards, Dan Byrne